Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice

被引：0
|
作者：
George M Warimwe
Gema Lorenzo
Elena Lopez-Gil
Arturo Reyes-Sandoval
Matthew G Cottingham
Alexandra J Spencer
Katharine A Collins
Matthew DJ Dicks
Anita Milicic
Amar Lall
Julie Furze
Alison V Turner
Adrian VS Hill
Alejandro Brun
Sarah C Gilbert
机构：
[1] University of Oxford,The Jenner Institute
[2] Instituto Nacional de Investigación Agraria y Alimentaria,Centro de Investigación en Sanidad Animal
来源：
Virology Journal | / 10卷
关键词：
Rift Valley Fever; Adenovirus vector; Vaccine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [31] Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines
    See, Raymond H.
    Petric, Martin
    Lawrence, David J.
    Mok, Catherine P. Y.
    Rowe, Thomas
    Zitzow, Lois A.
    Karunakaran, Karuna P.
    Voss, Thomas G.
    Brunham, Robert C.
    Gauldie, Jack
    Finlay, B. Brett
    Roper, Rachel L.
    JOURNAL OF GENERAL VIROLOGY, 2008, 89 : 2136 - 2146
  • [32] Safety and immunogenicity of the Chimpanzee-Adenovirus vectored Ebola vaccine: the Lausanne phase I/IIa clinical trial
    De Santis, O.
    Audran, R.
    Pothin, E.
    Warpelin-Decrausaz, L.
    Vallotton, L.
    Wuerzner, G.
    Cochet, C.
    Estoppey, D.
    Steiner-Monard, V.
    Lonchampt, S.
    Thierry, A. -C.
    Mayor, C.
    Bailer, R. T.
    Mbaya, O. Tshiani
    Zhou, Y.
    Ploquin, A.
    Sullivan, N. J.
    Graham, B. S.
    Roman, F.
    De Ryck, I.
    Ballou, R.
    Kieny, M. P.
    Moorthy, V.
    Spertini, F.
    Genton, B.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2015, 20 : 43 - 43
  • [33] An Oil-Based Adjuvant Improves Immune Responses Induced by Canine Adenovirus-Vectored Vaccine in Mice
    Broutin, Manon
    Costa, Fleur
    Peltier, Sandy
    Maye, Jennifer
    Versille, Nicolas
    Klonjkowski, Bernard
    VIRUSES-BASEL, 2023, 15 (08):
  • [34] A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques
    Hassan, Ahmed O.
    Feldmann, Friederike
    Zhao, Haiyan
    Curiel, David T.
    Okumura, Atsushi
    Tang-Huau, Tsing-Lee
    Case, James Brett
    Meade-White, Kimberly
    Callison, Julie
    Lovaglio, Jamie
    Hanley, Patrick W.
    Scott, Dana P.
    Fremont, Daved H.
    Feldmann, Heinz
    Diamond, Michael S.
    CELL REPORTS MEDICINE, 2021, 2 (04)
  • [35] A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters
    Bricker, Traci L.
    Darling, Tamarand L.
    Hassan, Ahmed O.
    Harastani, Houda H.
    Soung, Allison
    Jiang, Xiaoping
    Dai, Ya-Nan
    Zhao, Haiyan
    Adams, Lucas J.
    Holtzman, Michael J.
    Bailey, Adam L.
    Case, James Brett
    Fremont, Daved H.
    Klein, Robyn
    Diamond, Michael S.
    Boon, Adrianus C. M.
    CELL REPORTS, 2021, 36 (03):
  • [36] A novel Rift Valley fever vaccine
    Bronder, Saskia
    Sester, Martina
    LANCET INFECTIOUS DISEASES, 2023, 23 (08): : 887 - 889
  • [37] INACTIVATED RIFT VALLEY FEVER VACCINE
    BARNARD, BJH
    BOTHA, MJ
    JOURNAL OF THE SOUTH AFRICAN VETERINARY ASSOCIATION-TYDSKRIF VAN DIE SUID-AFRIKAANSE VETERINERE VERENIGING, 1977, 48 (01): : 45 - 48
  • [38] RIFT VALLEY FEVER VIRUS VACCINE
    RANDALL, R
    HARRISON, VR
    BINN, LN
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1963, 12 (04): : 611 - &
  • [39] Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study
    Rusnak, Janice M.
    Gibbs, Paul
    Boudreau, Ellen
    Clizbe, Denise P.
    Pittman, Phillip
    VACCINE, 2011, 29 (17) : 3222 - 3229
  • [40] Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience
    Pittman, PR
    Liu, CT
    Cannon, TL
    Makuch, RS
    Mangiafico, JA
    Gibbs, PH
    Peters, CJ
    VACCINE, 1999, 18 (1-2) : 181 - 189
12345